Pages that link to "Q44213485"
Jump to navigation
Jump to search
The following pages link to Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. (Q44213485):
Displaying 50 items.
- The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
- Time-Dependent Protection of CB2 Receptor Agonist in Stroke (Q27302924) (← links)
- Drug treatments for obesity: orlistat, sibutramine, and rimonabant. (Q30359088) (← links)
- Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. (Q30470076) (← links)
- Possible Anandamide and Palmitoylethanolamide involvement in human stroke (Q33446413) (← links)
- Neuroprotective therapies after perinatal hypoxic-ischemic brain injury (Q33772042) (← links)
- Neuronal Ca2+-Activated K+ Channels Limit Brain Infarction and Promote Survival (Q33786915) (← links)
- Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke (Q33793559) (← links)
- A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity (Q34011553) (← links)
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (Q34018061) (← links)
- Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. (Q34257520) (← links)
- Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. (Q34397288) (← links)
- Cannabinoids in experimental stroke: a systematic review and meta-analysis. (Q34452972) (← links)
- Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options (Q34549222) (← links)
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (Q34597537) (← links)
- Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? (Q34967151) (← links)
- Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia (Q35215113) (← links)
- Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context (Q35222716) (← links)
- Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities. (Q35228889) (← links)
- The endocannabinoid system: an overview (Q35828434) (← links)
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. (Q35870490) (← links)
- The endocannabinoid system and its therapeutic exploitation (Q35876026) (← links)
- Cannabinoid signaling in glial cells (Q35897353) (← links)
- Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (Q36103855) (← links)
- Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (Q36155898) (← links)
- Cannabinoid receptors and their role in neuroprotection (Q36211444) (← links)
- Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology (Q36345411) (← links)
- Cannabinoid receptors in acute and chronic complications of atherosclerosis. (Q36416368) (← links)
- Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning (Q36416372) (← links)
- Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (Q36431793) (← links)
- Epileptic stimulus increases Homer 1a expression to modulate endocannabinoid signaling in cultured hippocampal neurons (Q36460227) (← links)
- Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke (Q36802414) (← links)
- P2X7 receptors control 2-arachidonoylglycerol production by microglial cells (Q36854779) (← links)
- Endocannabinoids in cerebrovascular regulation (Q36895795) (← links)
- Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury (Q36961126) (← links)
- Role of cannabinoids and endocannabinoids in cerebral ischemia (Q36967863) (← links)
- Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (Q36980744) (← links)
- Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. (Q37015432) (← links)
- Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (Q37087780) (← links)
- Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. (Q37522043) (← links)
- The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. (Q37545714) (← links)
- Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. (Q37595794) (← links)
- The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (Q37793366) (← links)
- Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (Q37905540) (← links)
- Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. (Q38026790) (← links)
- Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury (Q38248001) (← links)
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (Q38563981) (← links)
- Genetic Manipulation of the Endocannabinoid System (Q38593120) (← links)
- Endocannabinoids and the Cardiovascular System in Health and Disease (Q38593133) (← links)
- Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases. (Q38664371) (← links)